申请人:INCHEON NATIONAL UNIVERSITY RESEARCH & BUSINESS FOUNDATION 인천대학교 산학협력단(220040217296) BRN ▼121-82-10382
公开号:KR101603038B1
公开(公告)日:2016-03-14
본 발명은 디설파이드-말단 아릴디아조늄(Disulfide-confined aryldiazonium salt; DSAD) 염 화합물 및 이의 제조방법에 관한 것으로, 더욱 상세하게는 전기화학적 산화에 의해 활성화되는 디설파이드 부분과 전극(ITO) 내지 환원된 그래핀 산화물(RGO)상에 그래프팅될 수 있는 아릴디아조늄 부분을 동시에 포함함으로써, 공간-선택적인(Spatially-selective) 표면 고정화가 가능하고, 항체 등 생체분자를 효과적으로 고정시킬 수 있어 면역분석법 및 면역센서 플랫폼의 생체분자 고정화용 링커(Linker) 분자로 유용하게 사용될 수 있는 신규한 구조의 디설파이드-말단 아릴디아조늄(DSAD) 염 화합물과, 이를 효율적으로 합성할 수 있는 제조방법에 관한 것이다.
New derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
申请人:SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S)
公开号:US20040019084A1
公开(公告)日:2004-01-29
The invention concerns novel lipoic acid derivatives, which have an inhibiting action with respect to NO-synthase enzymes producing nitrogen monoxide NO and/or are agents enabling the regeneration of antioxidants or entities trapping reactive oxygen species (ROS) and intervening in a more general manner in the redox status of thiol groups. The invention also concerns methods for preparing them, pharmaceutical compositions containing them and their use for therapeutic purposes, particularly their use as NO-synthase inhibitors and/or as agents acting more generally in the redox status of thiol groups.
The present invention relates to small molecules according to the formula [I]:
1
which are potent inhibitors of &agr;
4
&bgr;
1
mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing &agr;
4
&bgr;
1
adhesion mediated conditions in a mammal such as a human.